Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease
- PMID: 11823645
- DOI: 10.1126/science.1067389
Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease
Abstract
Parkinson's disease is a movement disorder characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta. Dopaminergic neuronal loss also occurs in Drosophila melanogaster upon directed expression of alpha-synuclein, a protein implicated in the pathogenesis of Parkinson's disease and a major component of proteinaceous Lewy bodies. We report that directed expression of the molecular chaperone Hsp70 prevented dopaminergic neuronal loss associated with alpha-synuclein in Drosophila and that interference with endogenous chaperone activity accelerated alpha-synuclein toxicity. Furthermore, Lewy bodies in human postmortem tissue immunostained for molecular chaperones, also suggesting that chaperones may play a role in Parkinson's disease progression.
Comment in
-
Neurobiology. Chaperones take flight.Science. 2002 Feb 1;295(5556):809-10. doi: 10.1126/science.1069544. Science. 2002. PMID: 11823628 No abstract available.
Similar articles
-
A Drosophila model of Parkinson's disease.Nature. 2000 Mar 23;404(6776):394-8. doi: 10.1038/35006074. Nature. 2000. PMID: 10746727
-
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x. J Neurochem. 2004. PMID: 15447678
-
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16. Proc Natl Acad Sci U S A. 2002. PMID: 12122208 Free PMC article.
-
Experimental models of Parkinson's disease.Nat Rev Neurosci. 2001 May;2(5):325-34. doi: 10.1038/35072550. Nat Rev Neurosci. 2001. PMID: 11331916 Review.
-
Alpha-synuclein and neurodegenerative diseases.Nat Rev Neurosci. 2001 Jul;2(7):492-501. doi: 10.1038/35081564. Nat Rev Neurosci. 2001. PMID: 11433374 Review. No abstract available.
Cited by
-
Opportunities and challenges for molecular chaperone modulation to treat protein-conformational brain diseases.Neurotherapeutics. 2013 Jul;10(3):416-28. doi: 10.1007/s13311-013-0186-5. Neurotherapeutics. 2013. PMID: 23536253 Free PMC article. Review.
-
Conservation of oxidative protein stabilization in an insect homologue of parkinsonism-associated protein DJ-1.Biochemistry. 2012 May 8;51(18):3799-807. doi: 10.1021/bi3003296. Epub 2012 Apr 24. Biochemistry. 2012. PMID: 22515803 Free PMC article.
-
Chaperones and Proteostasis: Role in Parkinson's Disease.Diseases. 2020 Jun 22;8(2):24. doi: 10.3390/diseases8020024. Diseases. 2020. PMID: 32580484 Free PMC article. Review.
-
The biology of proteostasis in aging and disease.Annu Rev Biochem. 2015;84:435-64. doi: 10.1146/annurev-biochem-060614-033955. Epub 2015 Mar 12. Annu Rev Biochem. 2015. PMID: 25784053 Free PMC article. Review.
-
A Simple Immunofluorescence Method to Characterize Neurodegeneration and Tyrosine Hydroxylase Reduction in Whole Brain of a Drosophila Model of Parkinson's Disease.Bio Protoc. 2024 Feb 20;14(4):e4937. doi: 10.21769/BioProtoc.4937. eCollection 2024 Feb 20. Bio Protoc. 2024. PMID: 38405079 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous